First-line IV artesunate treatment, a semisynthetic derivative of artemisinin, replaced quinine therapy for severe P.
A second-line triplet regimen involving the novel intravenous drug gedatolisib significantly reduced the risk of progression ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results